Search

Julienne Hearn Joins Sexton Riley LLP

Sexton Riley LLP is proud to announce that Julienne Hearn has joined the firm as a partner, as of October 1, 2021.


Julienne is a corporate and intellectual property lawyer with extensive experience advising biotechnology and pharmaceutical companies on strategic partnering matters.


Before joining Sexton Riley LLP in 2021, Julienne was a senior associate in the Strategic Transactions Practice Group of Ropes & Gray LLP, where she represented Johnson & Johnson, Biogen, Vertex Pharmaceuticals, Alexion Pharmaceuticals and other life sciences clients.





Recent Posts

See All

Janssen - argenx Cusatuzumab Collaboration

Sexton Riley LLP Represents Janssen Affiliate Cilag GmbH International in Worldwide Collaboration and License Agreement with argenx for Cancer Immunotherapy Cusatuzumab December 2018 ​Sexton Riley LLP

Janssen - Legend Biotech CAR-T Collaboration

Sexton Riley LLP Represents Janssen in Worldwide Collaboration and License Agreement with Chinese Company Legend Biotech to Develop Investigational CAR-T Anti-Cancer Therapy December 2017 ​Sexton Rile